Active ingredientGisadenafilCat. No. P-G034-001CAS 334826-98-1Family · Pharmaceutical analytical standards
Gisadenafil
A phosphodiesterase 5 (PDE5) inhibitor studied in the second half of the 2000s for urinary symptoms in men with benign prostatic hyperplasia; it has remained an investigational compound. This family brings together the active ingredient and labelled standards.
Did you know?It is about a hundred times more selective for PDE5 than for PDE6, the enzyme highly concentrated in the retina and involved in vision.
Go to the active ingredient →Active ingredientGisadenafilCat. No. P-G034-001CAS 334826-98-1
Active ingredientGisadenafil BesylateCat. No. P-G034-002CAS 334827-98-4
Isotopically labelledGisadenafil-d7Cat. No. P-G034-004No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.